Moderna, Inc. ( NASDAQ: MRNA) TD Cowen 45th Annual Health Care Conference March 5, 2025 9:10 AM ET All right, well, good morning, everyone. Tyler Van Buren here, Senior Biotech Analyst at TD Cowen.

If passed, anyone who provides or administers a gene-based vaccine to another person would face a penalty of $500 per violation.

Moderna Inc. expects to launch a personalized cancer vaccine that it’s developing with Merck & Co. by 2027, one of its top ...

Moderna (MRNA) stock in focus as the company aims a 2027 marketing nod for Merck (MRK) partnered skin cancer vaccine. Read ...

The FDA has ordered BioNTech to immediately halt its Phase I/II trial of malaria vaccine candidate BNT165e, pending changes.

A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna .

Shares of the American pharmaceutical company Moderna (MRNA) climbed over 8% in pre-market trading following strategic ...

Public health experts discuss lessons learned from the U.S. response to the COVID pandemic, on topics ranging from school ...

Across Indiana, fewer toddlers receive early childhood vaccines on schedule. Doctors are struggling to rebuild trust to prevent dangerous diseases.

Cornell University researchers used a new technology to design a vaccine that they say provides full protection against both ...

The COVID-19 vaccine has prompted more than 10 times as many reports of adverse symptoms than the measles vaccine.

A bill banning gene-based vaccines, like some forms of the COVID-19 vaccine, received approval from a Senate subcommittee ...